BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2824221)

  • 1. MK-801 stimulates the release of adrenocorticotrophin but not does affect the release of prolactin in the rat.
    Pechnick RN; George R; Poland RE
    Eur J Pharmacol; 1987 Sep; 141(2):323-4. PubMed ID: 2824221
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat.
    Pechnick RN; George R; Poland RE
    Eur J Pharmacol; 1989 May; 164(2):257-63. PubMed ID: 2547636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and behavioral effects of sigma and PCP ligands.
    Contreras PC; Contreras ML; O'Donohue TL; Lair CC
    Synapse; 1988; 2(3):240-3. PubMed ID: 2850629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel anticonvulsant MK-801 interacts with central phencyclidine recognition sites in rat brain.
    Loo PA; Braunwalder AF; Williams M; Sills MA
    Eur J Pharmacol; 1987 Mar; 135(2):261-3. PubMed ID: 3034630
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons.
    Steinfels GF; Tam SW; Cook L
    Neuropsychopharmacology; 1989 Sep; 2(3):201-8. PubMed ID: 2571340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of phencyclidine and sigma receptor types affecting the central inspiratory termination mechanism in cat.
    Foutz AS; Denavit-SaubiƩ M
    Life Sci; 1989; 45(14):1285-92. PubMed ID: 2554082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat.
    Rao TS; Kim HS; Lehmann J; Martin LL; Wood PL
    J Neurochem; 1990 Apr; 54(4):1157-62. PubMed ID: 2156013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
    Marquis KL; Paquette NC; Gussio RP; Moreton JE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs acting on sigma and phencyclidine receptors: a review of their nature, function, and possible therapeutic importance.
    Junien JL; Leonard BE
    Clin Neuropharmacol; 1989 Oct; 12(5):353-74. PubMed ID: 2558790
    [No Abstract]   [Full Text] [Related]  

  • 11. Sigma and PCP receptors in human frontal cortex membranes.
    Tam SW; Zhang AZ
    Eur J Pharmacol; 1988 Sep; 154(3):343-4. PubMed ID: 2853061
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
    Pechnick RN; George R; Poland RE; Hiramatsu M; Cho AK
    J Pharmacol Exp Ther; 1989 Aug; 250(2):534-40. PubMed ID: 2547936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple receptor types in opioid discrimination.
    Holtzman SG
    NIDA Res Monogr; 1986; 71():109-26. PubMed ID: 3025731
    [No Abstract]   [Full Text] [Related]  

  • 14. MK-801 protects the neonatal brain from hypoxic-ischemic damage.
    McDonald JW; Silverstein FS; Johnston MV
    Eur J Pharmacol; 1987 Aug; 140(3):359-61. PubMed ID: 2820765
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands.
    Sircar R; Samaan H; Nichtenhauser R; Snell LD; Johnson KM; Rivier J; Vale W; Zukin RS; Zukin SR
    NIDA Res Monogr; 1986; 75():157-60. PubMed ID: 2828962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative conformational analyses predict distinct receptor sites for PCP-like and sigma drugs.
    Manallack DT; Beart PM
    Eur J Pharmacol; 1987 Dec; 144(2):231-5. PubMed ID: 2830125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands.
    Davies SN; Martin D; Millar JD; Aram JA; Church J; Lodge D
    Eur J Pharmacol; 1988 Jan; 145(2):141-51. PubMed ID: 2832187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of sigma and phencyclidine receptor ligands with the norepinephrine uptake carrier in both rat brain and rat tail artery.
    Massamiri T; Duckles SP
    J Pharmacol Exp Ther; 1991 Feb; 256(2):519-24. PubMed ID: 1847198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiology. Taking apart NMDA receptors.
    Foster AC; Fagg GE
    Nature; 1987 Oct 1-7; 329(6138):395-6. PubMed ID: 2443852
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of sigma and phencyclidine receptor ligands on learning.
    Jones KW; Bauerle LM; DeNoble VJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):97-102. PubMed ID: 2163853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.